High Intensity Focused Ultrasound (HIFU) for the Treatment of Localized Prostate Cancer
Customize your policy alerts
Sign up for all Kaiser Permanente policy alerts
Know when Kaiser Permanente releases new policies or updates existing guidance.
Monitor payer policy activity
This clinical review criterion governs medical-necessity determinations for HIFU used to treat localized or recurrent localized prostate cancer for Kaiser Foundation Health Plan of Washington and Kaiser Foundation Health Plan of Washington Options, Inc. Coverage remains subject to the member’s Evidence of Coverage and applicable plan requirements.
Effective January 1, 2027, Kaiser Permanente adopted the MCG Urologic Surgery or Procedure GRG (SG-US) for medical-necessity determinations for focal subtotal image-guided prostate procedures.
The policy changes the non-Medicare HIFU position from not medically necessary through January 1, 2027, to medically necessary when the applicable criteria are met beginning January 1, 2027.
CPT code 55880 was added effective January 1, 2021.
Kaiser Permanente approved new HIFU criteria based on MCG urology procedure guidelines for prostate cancer, effective January 1, 2027.
Diagnosis codes for HIFU were removed from the applicable codes section in January 2022.
The applicable code listing was updated in December 2024.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.